FDA perspective on the need for revised performance goals for evaluating stenting of femoropopliteal arteries
- PMID: 24285586
- DOI: 10.1002/ccd.25221
FDA perspective on the need for revised performance goals for evaluating stenting of femoropopliteal arteries
Comment on
-
Safety and efficacy metrics for primary nitinol stenting in femoropopliteal occlusive disease: a meta-analysis and critical examination of current methodologies.Catheter Cardiovasc Interv. 2014 May 1;83(6):975-83. doi: 10.1002/ccd.25179. Epub 2014 Jan 31. Catheter Cardiovasc Interv. 2014. PMID: 23996913
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
